Liver-Selective Imidazolopyrazine Mitochondrial Uncoupler SHD865 Reverses Adiposity and Glucose Intolerance in Mice.

Publication Year: 2024

DOI:
10.2337/db23-0233

PMCID:
PMC10882157

PMID:
37870907

Journal Information

Full Title: Diabetes

Abbreviation: Diabetes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Duality of Interest. This study received support from Life Biosciences. K.L.H., W.L.S., J.M.C., and M.W. declare a financial interest in Life Biosciences. K.L.H. and W.L.S. declare a financial interest in Uncoupler Biosciences. S.P.T. declares a financial interest in Firebrick Pharma and Life Biosciences. No other potential conflicts of interest relevant to this article were reported."

Evidence found in paper:

"This work was supported in part by the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease Center for Scientific Review (R01DK128612), and the Australian National Health and Medical Research Council (GNT2014079). D.P.S., S.-Y.C., and S.J.A. were supported by UNSW Scientia PhD Scholarships."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025